Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Emcure Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:544210NSE Symbol: EMCUREP/E(TTM):64.15
ISIN Demat:INE168P01015Div & Yield %:0.22EPS(TTM):21.21
Book Value(Rs):159.546767Market Cap ( Cr.):25793.14Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 4381.923497.663107.093387.243153.662375.71
Excise Duty0.000.000.000.000.000.00
Net Sales4381.923497.663107.093387.243153.662375.71
Other Income 142.48138.26125.35132.68111.91137.62
Stock Adjustments 126.27101.70-14.4536.10107.96-59.70
Total Income4650.673737.623217.993556.023373.532453.63
EXPENDITURE :      
Raw Materials 2133.681464.671199.251354.991354.36751.46
Power & Fuel Cost99.8688.7380.4172.4673.9267.29
Employee Cost 782.31706.41649.18603.95550.96545.35
Other Manufacturing Expenses 275.56209.89192.67219.39142.20127.43
Selling and Administration Expenses 473.67532.82443.20263.11341.49342.04
Miscellaneous Expenses 119.95164.2795.59114.7873.58103.18
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure3885.033166.782660.302628.672536.511936.75
Operating Profit765.64570.83557.69927.36837.02516.88
Interest 112.96166.09166.83145.14123.34137.22
Gross Profit652.68404.74390.86782.22713.68379.66
Depreciation224.97204.83178.52165.79156.24154.97
Profit Before Tax427.71199.91212.34616.43557.44224.69
Tax112.7138.5853.10168.72141.1372.81
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-2.130.50-0.830.89-4.15-23.34
Reported Net Profit317.13160.83160.06446.81420.48175.21
Extraordinary Items 28.53-1.64-4.800.10-13.20-32.65
Adjusted Net Profit288.60162.47164.86446.71433.68207.86
Adjst. below Net Profit -1.21-5.344.06-0.790.11-2.03
P & L Balance brought forward1695.081593.841465.891877.111474.611349.71
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.0054.2636.17857.2418.0948.27
P & L Balance carried down2011.001695.081593.841465.891877.111474.61
Dividend0.0036.170.0036.170.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %30.0020.0020.0030.0010.0025.00
Earnings Per Share-Unit Curr16.748.888.8524.7123.259.69
Earnings Per Share(Adj)-Unit Curr16.74NANANANANA
Book Value-Unit Curr159.61106.82101.8494.69127.27105.86